Position in ESPR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
13,798
+7.4% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
8 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $273,087,606 across 29 Drug Manufacturers - Specialty & Generic names. ESPR ranks #29 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
|
10,680,100 | $110,966,238 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
3,887,179 | $67,287,068 | |
| 3 | ZTS |
Zoetis Inc.
|
634,661 | $45,606,739 | |
| 4 | ALKS |
Alkermes plc.
|
260,208 | $13,634,899 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
188,748 | $6,543,893 | |
| 6 | HLN |
Haleon plc
|
677,951 | $6,325,282 | |
| 7 | VTRS |
Viatris Inc
|
279,144 | $4,432,805 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
115,560 | $3,915,172 |
All Filings in ESPR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 13,798 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | — | 12,842 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | — | 14,455 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | — | 14,250 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | — | 12,356 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | — | 10,721 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | — | 10,721 | Shares | Defined | 2024-11-14 | |
| 2023-06-30 | — | 15,899 | Shares | Defined | 2023-08-11 | |
| No filing history on record for this holder in this stock. | ||||||